A detailed history of Kentucky Retirement Systems transactions in Abb Vie Inc. stock. As of the latest transaction made, Kentucky Retirement Systems holds 133,069 shares of ABBV stock, worth $25.9 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
133,069
Previous 134,080 0.75%
Holding current value
$25.9 Million
Previous $24.4 Million 6.52%
% of portfolio
0.67%
Previous 0.74%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $156,492 - $182,748
-1,011 Reduced 0.75%
133,069 $22.8 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.15 Million - $1.31 Million
-7,182 Reduced 5.08%
134,080 $24.4 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $825,600 - $929,820
6,000 Added 4.44%
141,262 $21.9 Million
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $880,491 - $1.02 Million
-6,591 Reduced 4.65%
135,262 $20.2 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $268,200 - $333,757
2,024 Added 1.45%
141,853 $19.1 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $118,435 - $136,396
819 Added 0.59%
139,829 $22.3 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $83,954 - $100,683
607 Added 0.44%
139,010 $22.5 Million
Q3 2022

Nov 16, 2022

BUY
$134.21 - $153.93 $973,022 - $1.12 Million
7,250 Added 5.53%
138,403 $18.6 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $2.54 Million - $3.23 Million
18,468 Added 16.39%
131,153 $20.1 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $1.03 Million - $1.28 Million
7,808 Added 7.44%
112,685 $18.3 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $332,388 - $420,567
3,094 Added 3.04%
104,877 $14.2 Million
Q3 2021

Nov 17, 2021

SELL
$106.4 - $120.78 $113,422 - $128,751
-1,066 Reduced 1.04%
101,783 $11 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $943,838 - $1.05 Million
-8,971 Reduced 8.02%
102,849 $11.6 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $24,245 - $26,690
237 Added 0.21%
111,820 $12.1 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $699,055 - $943,798
8,685 Added 8.44%
111,583 $12 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $411,165 - $482,572
4,786 Added 4.88%
102,898 $9.01 Million
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $211,672 - $283,249
-2,885 Reduced 2.86%
98,112 $9.63 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $1.61 Million - $2.44 Million
24,918 Added 32.75%
100,997 $7.7 Million
Q4 2019

Feb 18, 2020

BUY
$72.13 - $90.25 $23,009 - $28,789
319 Added 0.42%
76,079 $6.74 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $435,443 - $523,528
6,914 Added 10.04%
75,760 $5.74 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $286,123 - $365,732
4,355 Added 6.75%
68,846 $5.01 Million
Q1 2019

May 22, 2019

SELL
$77.14 - $90.79 $72,511 - $85,342
-940 Reduced 1.44%
64,491 $5.2 Million
Q4 2018

Feb 25, 2019

BUY
$77.85 - $96.01 $73,646 - $90,825
946 Added 1.47%
65,431 $6.03 Million
Q3 2018

Nov 19, 2018

SELL
$88.91 - $98.84 $5.94 Million - $6.61 Million
-66,859 Reduced 50.9%
64,485 $0
Q3 2018

Nov 16, 2018

BUY
$88.91 - $98.84 $5.96 Million - $6.62 Million
67,001 Added 104.13%
131,344 $0
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $1.69 Million - $2 Million
-18,850 Reduced 22.66%
64,343 $5.96 Million
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $1.39 Million - $1.86 Million
-15,110 Reduced 15.37%
83,193 $7.87 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $51,944 - $56,961
580 Added 0.59%
98,303 $9.51 Million
Q3 2017

Nov 08, 2017

SELL
$69.85 - $89.22 $300,494 - $383,824
-4,302 Reduced 4.22%
97,723 $8.68 Million
Q2 2017

Aug 18, 2017

BUY
N/A
102,025
102,025 $7.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kentucky Retirement Systems Portfolio

Follow Kentucky Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.